22NW, LP
CIK: 0001694297Latest portfolio: $237K · Q4 2025
Holdings
20
Total Value
$237K
New Positions
1
Closed Positions
2
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ANEBANEBULO PHARMACEUTICALS INC | 15,467,300 | $84K | 35.44% | — | |
| 2 | FSTRFOSTER L B CO | 1,191,046 | $32K | 13.50% | -122,075 | |
| 3 | LDELIFECORE BIOMEDICAL INC | 1,254 | $23K | 9.70% | — | |
| 4 | MLYSMINERALYS THERAPEUTICS INC | 358,325 | $13K | 5.49% | — | |
| 5 | RGNXREGENXBIO INC | 923,679 | $13K | 5.49% | — | |
| 6 | NKTRNEKTAR THERAPEUTICS | 331,115 | $13K | 5.49% | — | |
| 7 | SRISTONERIDGE INC | 2,192,764 | $12K | 5.06% | +87K | |
| 8 | MECMAYVILLE ENGR CO INC | 414,280 | $7K | 2.95% | +14K | |
| 9 | CULPCULP INC | 1,859,061 | $6K | 2.53% | — | |
| 10 | PFXPHENIXFIN CORP | 117,885 | $5K | 2.11% | — | |
| 11 | CMTCORE MOLDING TECHNOLOGIES | 222,738 | $4K | 1.69% | — | |
| 12 | MGTXMEIRAGTX HLDGS PLC | 586,519 | $4K | 1.69% | — | |
| 13 | NSPINSPERITY INC | 96,300 | $3K | 1.27% | NEW | |
| 14 | FARMFARMER BROS CO | 1,955,526 | $2K | 0.84% | — | |
| 15 | UFIUNIFI INC | 852,455 | $2K | 0.84% | -125,184 | |
| 16 | TISITEAM INC | 170,187 | $2K | 0.84% | — | |
| 17 | RZLTREZOLUTE INC | 820,653 | $1K | 0.42% | — | |
| 18 | E2OSTRATA SKIN SCIENCES INC | 536,995 | $0 | 0.00% | — | |
| 19 | ELDNELEDON PHARMACEUTICALS INC | 636,364 | $0 | 0.00% | — | |
| 20 | PMDIPSYCHEMEDICS CORPORATION CMN | 276,034 | $0 | 0.00% | — |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($131.3B)
Industrials0.0% ($32.7M)
Consumer Cyclical0.0% ($1.3M)
Technology0.0% ($840K)
Unknown0.0% ($230K)
Financial Services0.0% ($5K)
Basic Materials0.0% ($4K)
Consumer Defensive0.0% ($2K)
Filing History
Fund Information
22NW, LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $237K across 20 holdings. The largest position is ANEBULO PHARMACEUTICALS INC (ANEB), representing 35.4% of the portfolio. Compared to the previous quarter, the fund opened 1 new positions and closed 2 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.